Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/18/2025

Septic Shock Secondary to Erythroderma: Treatment Approach

Immediate Management

  • The American College of Critical Care Medicine recommends administering IV broad-spectrum antibiotics within 60 minutes of septic shock recognition, covering both gram-positive and gram-negative pathogens with empiric combination therapy using at least two different antimicrobial classes 1, 2
  • Obtain at least two sets of blood cultures before starting antibiotics, but never delay antimicrobials beyond 45 minutes waiting for cultures, as recommended by the Society of Critical Care Medicine 2, 3
  • Administer at least 30 mL/kg of isotonic crystalloids in the first 3 hours, as suggested by the Critical Care Medicine guidelines 4
  • Initiate norepinephrine as first-line vasopressor if hypotension persists despite adequate fluid resuscitation, according to the Intensive Care Medicine guidelines 1, 4

Source Control and Dermatologic Management

  • The Intensive Care Medicine guidelines recommend identifying and treating the underlying cause of erythroderma, and considering systemic corticosteroids or other immunosuppressive therapy in consultation with dermatology, balancing infection risk 1

Antimicrobial De-escalation and Duration

  • Reassess antimicrobial regimen daily for potential de-escalation once culture results and sensitivities return, and discontinue combination therapy after 3-5 days, as recommended by the Intensive Care Medicine guidelines 1, 2, 5
  • Standard duration of treatment is 7-10 days for septic shock secondary to skin/soft tissue source, according to the Intensive Care Medicine guidelines 1, 5, 6

Adjunctive Therapies

  • Consider hydrocortisone (200 mg/day) only in refractory septic shock poorly responsive to fluids and vasopressors, as suggested by the Critical Care Medicine guidelines 4
  • Target hemoglobin 7-9 g/dL unless active hemorrhage, tissue hypoperfusion, or coronary disease present, according to the Critical Care Medicine guidelines 4

REFERENCES